Skip to main content

APLS

Apellis Pharmaceuticals, Inc.
Last price
$41.03
As of

Active signals for APLS

No recent signals on APLS in the last 180 days.

Top institutional holders of APLS (13F)

FundMarket value% portfolioQoQ
Point72 Asset Management, L.P.$168.3M0.22%+600.0%
SOROS FUND MANAGEMENT LLC$42.5M0.47%,
RENAISSANCE TECHNOLOGIES LLC$37.7M0.06%+47.8%
TWO SIGMA INVESTMENTS, LP$21M0.02%-7.2%
RENAISSANCE TECHNOLOGIES LLC$16.4M0.02%,
RENAISSANCE TECHNOLOGIES LLC$15.9M0.02%-12.4%
Point72 Asset Management, L.P.$15M0.02%+175.3%
TWO SIGMA INVESTMENTS, LP$14.1M0.02%+123.1%
D. E. Shaw & Co., Inc.$7.5M0.00%+1244.3%
TWO SIGMA INVESTMENTS, LP$5.7M0.01%,
D. E. Shaw & Co., Inc.$5.3M0.00%+0.0%
D. E. Shaw & Co., Inc.$5.2M0.00%+0.0%
D. E. Shaw & Co., Inc.$5.2M0.00%,
Point72 Asset Management, L.P.$4.9M0.01%,
Bridgewater Associates, LP$3.6M0.01%,
CITADEL ADVISORS LLC$3.1M0.00%+9.0%
CITADEL ADVISORS LLC$2.6M0.00%,
D. E. Shaw & Co., Inc.$1.7M0.00%,
Bridgewater Associates, LP$1.4M0.01%-75.7%
D. E. Shaw & Co., Inc.$349K0.00%-81.6%

Sourced from quarterly 13F filings with the U.S. Securities and Exchange Commission.

Recent SEC filings, APLS

See more APLS signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Sign in to track APLS in your watchlist and get notified the moment a new signal fires.

Track APLS on Kresmion →